---
title: Pfizer Leaders Discuss the Adoption of Open Source, Predominantly R, in Clinical
  Trial Reporting
date: '2023-11-09'
linkTitle: https://www.r-bloggers.com/2023/11/pfizer-leaders-discuss-the-adoption-of-open-source-predominantly-r-in-clinical-trial-reporting/
source: R-bloggers
description: |-
  <div style = "width:60%; display: inline-block; float:left; "> In this PHUSE video interview, Pfizer is making strides in incorporating open source tools into its clinical reporting processes. Michael Rimler, PHUSE Open Source Technologies Director, brings in Mike Smith,...<br />
  The post Pfizer Leaders Discuss the Adoption of Open Source, Predominantly R, in Clinical Trial Reporting appeared first on R ...</div>
  <div style = "width: 40%; display: inline-block; float:right;"></div>
  <div style="clear: both;"></div>
  <strong>Continue reading</strong>: <a href="https://www.r-bloggers.com/2023/11/pfiz ...
disable_comments: true
---
<div style = "width:60%; display: inline-block; float:left; "> In this PHUSE video interview, Pfizer is making strides in incorporating open source tools into its clinical reporting processes. Michael Rimler, PHUSE Open Source Technologies Director, brings in Mike Smith,...<br />
The post Pfizer Leaders Discuss the Adoption of Open Source, Predominantly R, in Clinical Trial Reporting appeared first on R ...</div>
<div style = "width: 40%; display: inline-block; float:right;"></div>
<div style="clear: both;"></div>
<strong>Continue reading</strong>: <a href="https://www.r-bloggers.com/2023/11/pfiz ...